CoChat

A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers

Glover, Elbert D., Laflin, Molly T., Schuh, Kory J., Schuh, Leslie M., Nides, Mitch, Christen, Arden G., Glover, Penny N., Strnad, Julia V. · 2007 · Addiction
Cited by 38

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims To determine the efficacy and safety of nicotine transdermal therapy co‐administered with the nicotine antagonist, mecamylamine, compared to a nicotine transdermal patch alone (21 mg nicotine + 6 mg mecamylamine, 21 mg nicotine + 3 mg mecamylamine, and 21 mg nicotine + 0 mg mecamylamine). Design Multi‐center (n = 4), double‐blind, randomized, parallel group, repeat‐dose study. Setting Clinical laboratory. Participants A total of 540 subjects were enrolled into the study—135 from each of four sites; 180 patients in each of three treatment arms. Intervention Treatment was administered for the first 6 weeks of the 8‐week study. Patients were instructed to continue smoking for the first 2 weeks of treatment. Measurements The primary efficacy parameter was 4‐week continuous abstinence after the quit date, confirmed with an expired carbon monoxide of < 10 parts per million. Findings Analysis of the 4‐week continuous abstinence for the intent‐to‐treat population showed overall rates of 29% (nicotine + 6 mg mecamylamine), 29% (nicotine + 3 mg mecamylamine) and 23% (nicotine only) using the slip definition which allows smoking in the first 2 weeks after the quit date. Statistical analyses revealed no significant treatment differences. Analyses using the strict definition (no smoking after the quit date) yielded similar non‐significant group differences (29%, 27%, 26%). Conclusion If adding mecamylamine to nicotine replacement therapy (NRT) improves the chances of success at stopping smoking, the results of this study suggest that the effect is very small.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1360-0443.2007.01763.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 38

Metadata

Authors
Glover, E. D., Laflin, M. T., Schuh, K. J., Schuh, L. M., Nides, M., Christen, A. G., Glover, P. N., & Strnad, J. V.
Venue
Addiction
Publisher
Wiley
Published
2007-03-02
Volume
102
Issue
5
Pages
795-802
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2001605886
Cited by
38
References
4
FWCI
3.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.01763.x
The paper
Glover, E. D., Laflin, M. T., Schuh, K. J., Schuh, L. M., Nides, M., Christen, A. G., Glover, P. N., & Strnad, J. V. (2007). A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01763.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.